Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > What is going wrong for XORTX?
View:
Post by NLMoose on Oct 19, 2021 7:14pm

What is going wrong for XORTX?

While XORTX Therapeutics has achieved several major milestones lately, including a 1 for 11 share consolidation, a listing in one of the world's most recognized stock exchanges like NASDAQ, and good findings from recent clinical trials, the company is getting disproportionately punished as its share price lost nearly 50% of its market value in less than a week?

Due to these recent string of good news, XORTX should be properly rewarded for the positive news, not punished for it with their stock plunging nearly 50%.

Its ok for a company's stock to go down in value if they incurred hefty losses or miss revenue/profit targets, but not when it reports one piece of great news after another.

ENOUGH IS ENOUGH, time for XORTX shares to go back up to at least $6.00 a share.

Otherwise, XORTX will be the "Kraken Robotics" of NASDAQ, referring to a St. John's based tech company known for reporting great news, but gets punished for it with share prices hovering at one year lows.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities